Right now the pharmaceutical oligarchs have a problem. They have to find some update to the jab to put out for fall. But if it performs worse than the current formulations, it will be all too obvious. Nothing Omicron-related is likely to perform better (see GVB and others), and the current formulation is going downhill. So perhaps the on…
Right now the pharmaceutical oligarchs have a problem. They have to find some update to the jab to put out for fall. But if it performs worse than the current formulations, it will be all too obvious. Nothing Omicron-related is likely to perform better (see GVB and others), and the current formulation is going downhill. So perhaps the only thing they can do is push Covid into the background and juice up the Pox, and/or punt to an mRNA flu jab. It is a conundrum.
Right now the pharmaceutical oligarchs have a problem. They have to find some update to the jab to put out for fall. But if it performs worse than the current formulations, it will be all too obvious. Nothing Omicron-related is likely to perform better (see GVB and others), and the current formulation is going downhill. So perhaps the only thing they can do is push Covid into the background and juice up the Pox, and/or punt to an mRNA flu jab. It is a conundrum.